36 results
DEFM14A
ORTX
Orchard Therapeutics plc
16 Nov 23
Proxy related to merger
4:45pm
;
environmental matters;
compliance with anti-bribery, anti-corruption and anti-money laundering laws;
insurance policies;
absence of certain affiliate … Matters
A-33
Section 4.23
FCPA; Anti-Corruption; Sanctions
A-33
Section 4.24
Insurance
A-34
Section 4.25
Transactions with Affiliates
A-34
Section 4.26
PREM14A
ORTX
Orchard Therapeutics plc
3 Nov 23
Preliminary proxy related to merger
5:11pm
and leased real property;
environmental matters;
compliance with anti-bribery, anti-corruption and anti-money laundering laws;
insurance policies;
absence …
Privacy and Data Protection
A-31
Section 4.21
Properties
A-32
Section 4.22
Environmental Matters
A-33
Section 4.23
FCPA; Anti-Corruption; Sanctions
DEFA14A
ORTX
Orchard Therapeutics plc
5 Oct 23
Additional proxy soliciting materials
9:07am
Section 4.23
FCPA; Anti-Corruption; Sanctions
Section 4.24
Insurance
Section 4.25
Transactions with Affiliates
Section 4.26
Antitakeover Statutes … has any liability that relates to or arises under, or has violated, any Environmental Law or Environmental Permit.
Section 4.23 FCPA; Anti-Corruption; Sanctions
8-K
EX-2.1
ORTX
Orchard Therapeutics plc
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
to or arises under, or has violated, any Environmental Law or Environmental Permit.
Section 4.23 FCPA; Anti-Corruption; Sanctions.
(a) Except as has …
Intellectual Property
Section 4.20
Privacy and Data Protection
Section 4.21
Properties
Section 4.22
Environmental Matters
Section 4.23
FCPA; Anti
8-K
EX-1.1
dehqa
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
8-K
EX-10.1
y4nvvy9bhaf s0l9
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am